driven by the PitchBook Platform
Developer of drug candidates for the treatment of hypertension and epilepsy. The company's drug candidates are based on novel no-donor compounds that do not evoke pro-drug tolerance.
You’re viewing a free company profile from the PitchBook Platform. To explore Renopharm’s full profile, request a free trial.
© 2017 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.